UBS Group AG Has $15.33 Million Position in Dolby Laboratories $DLB

UBS Group AG lessened its stake in shares of Dolby Laboratories (NYSE:DLBFree Report) by 41.7% during the fourth quarter, Holdings Channel reports. The fund owned 238,626 shares of the electronics maker’s stock after selling 170,747 shares during the quarter. UBS Group AG’s holdings in Dolby Laboratories were worth $15,325,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of DLB. Royal Bank of Canada lifted its position in shares of Dolby Laboratories by 3.5% during the 1st quarter. Royal Bank of Canada now owns 68,367 shares of the electronics maker’s stock valued at $5,491,000 after acquiring an additional 2,298 shares during the period. Goldman Sachs Group Inc. lifted its position in shares of Dolby Laboratories by 218.8% during the 1st quarter. Goldman Sachs Group Inc. now owns 249,574 shares of the electronics maker’s stock valued at $20,043,000 after acquiring an additional 171,288 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in shares of Dolby Laboratories by 5.6% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 238,216 shares of the electronics maker’s stock valued at $19,131,000 after acquiring an additional 12,598 shares during the period. Focus Partners Wealth acquired a new position in shares of Dolby Laboratories during the 1st quarter valued at $390,000. Finally, EverSource Wealth Advisors LLC increased its stake in Dolby Laboratories by 273.3% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,598 shares of the electronics maker’s stock valued at $193,000 after purchasing an additional 1,902 shares in the last quarter. Institutional investors and hedge funds own 58.56% of the company’s stock.

Insider Transactions at Dolby Laboratories

In other news, SVP Shriram Revankar sold 3,000 shares of the company’s stock in a transaction on Tuesday, February 17th. The shares were sold at an average price of $66.14, for a total value of $198,420.00. Following the completion of the sale, the senior vice president owned 83,218 shares in the company, valued at $5,504,038.52. This represents a 3.48% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, SVP John D. Couling sold 7,666 shares of the company’s stock in a transaction on Tuesday, May 5th. The stock was sold at an average price of $57.55, for a total transaction of $441,178.30. Following the completion of the sale, the senior vice president owned 118,353 shares of the company’s stock, valued at approximately $6,811,215.15. The trade was a 6.08% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 18,021 shares of company stock worth $1,090,741 in the last quarter. 37.93% of the stock is currently owned by corporate insiders.

Dolby Laboratories Trading Down 2.0%

Shares of DLB stock opened at $54.28 on Thursday. The firm has a market capitalization of $5.14 billion, a PE ratio of 21.46 and a beta of 0.86. The firm has a fifty day simple moving average of $61.52 and a two-hundred day simple moving average of $63.94. Dolby Laboratories has a 12 month low of $53.45 and a 12 month high of $77.64.

Dolby Laboratories (NYSE:DLBGet Free Report) last posted its earnings results on Thursday, April 30th. The electronics maker reported $1.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.31 by $0.06. Dolby Laboratories had a net margin of 17.85% and a return on equity of 11.47%. The firm had revenue of $395.63 million during the quarter, compared to analyst estimates of $385.80 million. During the same quarter in the prior year, the business posted $1.34 EPS. The business’s revenue was up 7.0% compared to the same quarter last year. Dolby Laboratories has set its FY 2026 guidance at 4.300-4.450 EPS and its Q3 2026 guidance at 0.560-0.710 EPS. On average, equities analysts predict that Dolby Laboratories will post 3.22 earnings per share for the current fiscal year.

Dolby Laboratories Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, May 20th. Stockholders of record on Tuesday, May 12th will be paid a $0.36 dividend. The ex-dividend date is Tuesday, May 12th. This represents a $1.44 annualized dividend and a dividend yield of 2.7%. Dolby Laboratories’s dividend payout ratio is presently 56.92%.

Wall Street Analyst Weigh In

A number of analysts have commented on DLB shares. Rosenblatt Securities restated a “buy” rating and set a $85.00 price target on shares of Dolby Laboratories in a research note on Friday, January 30th. Weiss Ratings restated a “hold (c-)” rating on shares of Dolby Laboratories in a research note on Friday, March 27th. Wall Street Zen lowered shares of Dolby Laboratories from a “buy” rating to a “hold” rating in a research note on Saturday, January 31st. Finally, Barrington Research restated an “outperform” rating and set a $90.00 price target on shares of Dolby Laboratories in a research note on Monday, April 27th. Three research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat, Dolby Laboratories currently has an average rating of “Moderate Buy” and a consensus target price of $90.75.

Read Our Latest Research Report on Dolby Laboratories

Dolby Laboratories Company Profile

(Free Report)

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.

Featured Articles

Want to see what other hedge funds are holding DLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dolby Laboratories (NYSE:DLBFree Report).

Institutional Ownership by Quarter for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.